VIVEbiotech Featured in PharmaSource
Natalia Elizalde shares key insights on flexible and cost-efficient CDMO contracts alongside leading industry experts.
We are proud to be featured in PharmaSource in the article “How to negotiate CDMO Contracts for Flexibility and Cost Control”.
Our Chief Business Development Officer, Natalia Elizalde highlights strategies for structuring CDMO contracts that balance flexibility and cost efficiency, particularly in early-stage programs where uncertainty is highest.
The article brings together insights from nine industry leaders, including AustinPx, Likarda, Autolomous, ExMmoor Pharma, Title21, CellProthera and Cohance Lifesciences. They discuss modular contracts, milestone-based approaches, digital transparency, risk-sharing, and strategic partnerships.
This feature underscores VIVEbiotech’s commitment to innovative, collaborative, and adaptive approaches in pharmaceutical development.